Screener
CytomX Therapeutics CTMX Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from CytomX Therapeutics’s reported figures.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
FAQ
- What is CytomX Therapeutics's invested capital?
- CytomX Therapeutics (CTMX) reported invested capital of $290.55M in Q2 2026.
- How has CytomX Therapeutics's invested capital changed year-over-year?
- CytomX Therapeutics's invested capital increased by 273.7% year-over-year, from $77.75M to $290.55M.
- What is the long-term trend for CytomX Therapeutics's invested capital?
- Over 5 years (2020 to 2025), CytomX Therapeutics's invested capital has grown at a -12.3% compound annual growth rate (CAGR), from -$174.76M to $90.58M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about CytomX Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude